Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Flühler V, et al. Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Front Immunol. 2022;13:826164 pubmed publisher

Meyers L, Gutiérrez A, Boyle C, Terry F, McGonnigal B, Salazar A, et al. Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. NPJ Vaccines. 2021;6:71 pubmed publisher

Nemattalab M, Shenagari M, Taheri M, Mahjoob M, Nazari Chamaki F, Mojtahedi A, et al. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice. Cytokine. 2020;126:154866 pubmed publisher

Rodrigues da Silva R, Correa Moreira D, Soares I, De Luca P, Totino P, Morgado F, et al. Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9. Vaccine. 2019;37:306-313 pubmed publisher

Dobrica M, Lazar C, Paruch L, van Eerde A, Clarke J, Tucureanu C, et al. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Vaccine. 2018;36:5789-5795 pubmed publisher

Petkov S, Starodubova E, Latanova A, Kilpelainen A, Latyshev O, Svirskis S, et al. DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response. PLoS ONE. 2018;13:e0197902 pubmed publisher

Hjertner B, Bengtsson T, Morein B, Paulie S, Fossum C. A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine. Vaccine. 2018;36:3340-3344 pubmed publisher

Magnusson S, Altenburg A, Bengtsson K, Bosman F, de Vries R, Rimmelzwaan G, et al. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice. Immunol Res. 2018;66:224-233 pubmed publisher

Dobrica M, Lazar C, Paruch L, Skomedal H, Steen H, Haugslien S, et al. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein. Antiviral Res. 2017;144:256-265 pubmed publisher

Altenburg A, Magnusson S, Bosman F, Stertman L, de Vries R, Rimmelzwaan G. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice. Clin Exp Immunol. 2017;190:19-28 pubmed publisher

Krotova O, Starodubova E, Petkov S, Kostic L, Agapkina J, Hallengärd D, et al. Consensus HIV-1 FSU-A integrase gene variants electroporated into mice induce polyfunctional antigen-specific CD4+ and CD8+ T cells. PLoS ONE. 2013;8:e62720 pubmed publisher